X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5094) 5094
Publication (412) 412
Newspaper Article (87) 87
Book Review (47) 47
Newsletter (41) 41
Book Chapter (11) 11
Dissertation (7) 7
Transcript (5) 5
Conference Proceeding (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3999) 3999
oncology (3698) 3698
carboplatin (3405) 3405
female (3051) 3051
chemotherapy (3034) 3034
index medicus (2942) 2942
middle aged (2460) 2460
aged (2335) 2335
paclitaxel (2316) 2316
antineoplastic combined chemotherapy protocols - therapeutic use (2294) 2294
cancer (2010) 2010
male (1896) 1896
adult (1880) 1880
carboplatin - administration & dosage (1786) 1786
cisplatin (1630) 1630
lung neoplasms - drug therapy (1569) 1569
paclitaxel - administration & dosage (1456) 1456
carcinoma, non-small-cell lung - drug therapy (1438) 1438
treatment outcome (1289) 1289
antineoplastic combined chemotherapy protocols - adverse effects (1033) 1033
care and treatment (1010) 1010
neoplasm staging (998) 998
lung neoplasms - pathology (929) 929
trial (835) 835
aged, 80 and over (829) 829
lung cancer, non-small cell (821) 821
disease-free survival (818) 818
ovarian cancer (816) 816
lung cancer (794) 794
gemcitabine (781) 781
survival (780) 780
carcinoma, non-small-cell lung - pathology (778) 778
research (766) 766
carcinoma (752) 752
ovarian neoplasms - drug therapy (747) 747
cisplatin - administration & dosage (739) 739
bevacizumab (730) 730
combination (689) 689
antineoplastic agents - therapeutic use (632) 632
phase-iii trial (631) 631
medicine & public health (627) 627
survival rate (626) 626
prognosis (615) 615
therapy (615) 615
docetaxel (608) 608
hematology, oncology and palliative medicine (594) 594
carboplatin - adverse effects (590) 590
cancer therapies (579) 579
survival analysis (575) 575
pharmacology & pharmacy (567) 567
non-small cell lung cancer (561) 561
clinical trials (552) 552
lung neoplasms - mortality (527) 527
retrospective studies (526) 526
analysis (521) 521
drug administration schedule (517) 517
antineoplastic agents (513) 513
antineoplastic combined chemotherapy protocols - administration & dosage (512) 512
deoxycytidine - analogs & derivatives (510) 510
drug therapy (503) 503
tumors (493) 493
metastasis (492) 492
carcinoma, non-small-cell lung - mortality (487) 487
antimitotic agents (479) 479
patients (474) 474
paclitaxel - adverse effects (457) 457
deoxycytidine - administration & dosage (443) 443
respiratory system (436) 436
obstetrics & gynecology (432) 432
combined modality therapy (405) 405
radiotherapy (396) 396
health aspects (382) 382
carboplatin - therapeutic use (380) 380
phase-ii trial (376) 376
ovarian neoplasms - pathology (375) 375
open-label (373) 373
surgery (367) 367
toxicity (362) 362
phase-ii (359) 359
randomized-trial (356) 356
gefitinib (353) 353
cell lung-cancer (352) 352
oncology, experimental (352) 352
platinum (342) 342
cancer research (339) 339
1st-line treatment (337) 337
phase-iii (328) 328
breast cancer (317) 317
antineoplastic agents - administration & dosage (315) 315
follow-up studies (314) 314
mutation (305) 305
neoplasm recurrence, local - drug therapy (302) 302
cyclophosphamide (299) 299
taxoids - administration & dosage (298) 298
vinorelbine (298) 298
erlotinib (295) 295
nsclc (289) 289
paclitaxel - therapeutic use (287) 287
pharmacology/toxicology (287) 287
multicenter (286) 286
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5163) 5163
Japanese (36) 36
French (20) 20
Chinese (17) 17
German (15) 15
Spanish (3) 3
Korean (2) 2
Italian (1) 1
Polish (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1360 - 1372
Journal Article
The Oncologist, ISSN 1083-7159, 06/2007, Volume 12, Issue 6, pp. 713 - 718
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 101 - 114
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 187 - 199
Summary Background We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | COMPETING RISK | CLINICAL-TRIALS | THERAPY ONCOLOGY GROUP | CHEMORADIATION | INDUCTION | CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Radiotherapy, Image-Guided | Chemoradiotherapy | Carcinoma, Large Cell - secondary | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Carcinoma, Squamous Cell - mortality | Aged, 80 and over | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Radiotherapy Dosage | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Adenocarcinoma - secondary | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Radiotherapy, Conformal | Carcinoma, Squamous Cell - secondary | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Chemotherapy | Dosage and administration | Lung cancer, Non-small cell | Antineoplastic agents | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4349 - 4357
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 779 - 791
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 436 - 446
Journal Article